Skip to main content
Tadiran Group Ltd. logo

Tadiran Group Ltd. — Investor Relations & Filings

Ticker · TDRN ISIN · IL0002580129 TA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 169 across all filing types
Latest filing 2023-03-07 Regulatory Filings
Country IL Israel
Listing TA TDRN

About Tadiran Group Ltd.

https://www.tadiran-group.co.il

Tadiran Group Ltd. is a company specializing in advanced climate control and renewable energy solutions. The company develops, imports, and distributes a wide range of air conditioning systems for residential and light commercial applications, with a significant focus on indoor air quality through integrated air purification and disinfection technologies. In the energy sector, Tadiran provides a comprehensive portfolio of solutions including solar energy systems, energy storage, heat pumps for water and space heating, and electric vehicle charging stations. The company's offerings aim to create an ecosystem for energy efficiency and sustainability.

Recent filings

Filing Released Lang Actions
Form 8.5 (EPT/NON-RI)
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 8.5 (EPT/NON-RI)' and explicitly references 'Rule 8.5 of the Takeover Code'. It details 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER' concerning securities of 'Mediclinic International Plc' in relation to an offer. This type of mandatory disclosure regarding insider/principal trader positions and dealings during a takeover period is a specific regulatory filing. Since it is a specific regulatory disclosure related to takeover activity and not a general announcement, it fits best under the 'Regulatory Filings' category (RNS) as a specific type of required disclosure, although it is highly specific. Given the options, 'RNS' is the most appropriate general regulatory filing category for disclosures mandated by bodies like the Takeover Panel that don't fit other specific categories like DIRS (Director's Dealing) or TAR (M&A Activity itself). However, since it is a mandatory disclosure about dealings/positions during an offer, it is a specific regulatory filing. If 'DIRS' (Director's Dealing) were broader, it might fit, but this is specifically about an Exempt Principal Trader under the Takeover Code. Given the context of mandatory regulatory reporting via RNS, RNS is the best fit among the provided codes for this specific form type.
2023-03-07 English
Form 8.5 (EPT/NON-RI)
Director's Dealing Classification · 95% confidence The document is explicitly titled 'FORM 8.5 (EPT/NON-RI)' and references 'Rule 8.5 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER'. Such disclosures, especially those related to takeover codes and insider/principal trader positions, are specific regulatory filings concerning transactions or holdings, often related to M&A activity or insider reporting. While it relates to a potential takeover (Mediclinic International Plc is mentioned as the offeree), the core function of Form 8.5 is reporting director/insider dealings or positions during an offer period. This aligns most closely with 'Director's Dealing' (DIRS) or a specific regulatory disclosure. Given the context of the Takeover Code and disclosure of positions/dealings by a principal trader connected to an offer, it is a specialized insider/director transaction report. Since 'DIRS' covers director/executive share transactions, and this is a mandatory disclosure of a principal trader's position/dealing during a takeover context, it falls under the umbrella of insider transaction reporting. However, since the provided definitions do not have a specific code for 'Takeover Code Disclosure Form 8.5', we must choose the closest fit. 'DIRS' (Director's Dealing) is the closest category for reporting personal share transactions by executives/insiders. If it were purely an announcement of a report, RPA/RNS would apply, but this *is* the required disclosure itself. Given the nature of the disclosure (position/dealing), DIRS is the most appropriate fit among the options, although it is technically a specific type of insider filing.
2023-03-06 English
Form 8.5 (EPT/NON-RI)
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'FORM 8.5 (EPT/NON-RI)' and references 'Rule 8.5 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER'. Such disclosures, especially those related to takeover codes and dealing by principal traders, are regulatory announcements disseminated via services like RNS (Regulatory News Service). While it details specific dealings (Section 3), its primary function is a mandatory disclosure related to a potential offer (Mediclinic International Plc). Since there is no specific code for 'Takeover Disclosure' or 'Insider Dealing Disclosure' that perfectly matches this regulatory form, and it is a mandatory regulatory filing disseminated through RNS, the most appropriate classification is the general regulatory filing category, RNS, as it is a specific type of regulatory announcement not covered by DIRS (Director's Dealing, which is usually for company officers, not exempt principal traders in a takeover context) or TAR (M&A Activity, which is usually the proposal itself). Given the context of RNS distribution and the nature of the filing, RNS is the best fit among the provided options for a mandatory regulatory disclosure.
2023-03-03 English
Form 8.5 (EPT/NON-RI)
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.5 (EPT/NON-RI)' and references 'Rule 8.5 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER' in relation to an offer (here, Mediclinic International Plc). This type of disclosure relates to insider trading or transactions by parties involved in a takeover situation. While it involves dealings, the specific regulatory form (Form 8.5) and the context of a takeover bid strongly suggest it is a specialized regulatory filing concerning insider transactions during an offer period. Since there is no specific category for 'Takeover Bid Insider Dealing Disclosure', and it is a mandatory regulatory filing disseminated via RNS, the most appropriate classification is the general 'Regulatory Filings' (RNS), as it is a specific regulatory disclosure not covered by DIRS (which is typically for routine director dealings outside of a formal offer context) or TAR (which is for the M&A announcement itself). Given the presence of 'RNS Number' and the footer mentioning RNS as the news service, RNS is the best fit for this specific regulatory disclosure format.
2023-03-02 English
Form 8.5 (EPT/NON-RI)
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'FORM 8.5 (EPT/NON-RI)' and references 'Rule 8.5 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER'. Such disclosures regarding dealings or positions related to a takeover offer are mandatory regulatory filings, often disseminated via an RNS (Regulatory Information Service). Since the content details specific dealings and positions under takeover rules, it falls under the category of mandatory regulatory disclosure that doesn't fit the more specific financial report types (like 10-K, ER, IR). While it is a regulatory filing, the specific nature of director/insider dealing disclosures related to takeovers often aligns closely with insider trading reports or general regulatory announcements. Given the options, 'Director's Dealing' (DIRS) is for personal transactions by directors, and this is a principal trader disclosure related to an offer. 'Major Shareholding Notification' (MRQ) is for changes in significant ownership thresholds. Since this is a specific disclosure mandated by the Takeover Code regarding trading activity during an offer period, and it is disseminated via RNS, the most appropriate general regulatory category that captures specific, non-standard disclosures is 'Regulatory Filings' (RNS), although 'Director's Dealing' (DIRS) is conceptually close as it involves insider/connected party trading disclosures. However, Form 8.5 is specifically about principal traders in the context of a takeover, which is a distinct regulatory event. Given the structure and the RNS header, RNS is the safest general regulatory classification when a more specific insider/director dealing code doesn't perfectly match the 'Exempt Principal Trader' context under the Takeover Code. Upon review, DIRS is for directors/executives. This is a principal trader disclosure. Therefore, RNS is the best fit as a general regulatory filing.
2023-03-01 English
Form 8.5 (EPT/NON-RI)
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'FORM 8.5 (EPT/NON-RI)' and references 'Rule 8.5 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER'. Such disclosures, especially those related to takeover codes and insider/principal trader activity, are mandatory regulatory announcements disseminated via services like RNS (Regulatory News Service). While it details dealings (which might suggest DIRS), the specific structure and reference to the Takeover Code (Rule 8.5) make it a specialized regulatory filing concerning an ongoing offer/takeover situation. Since there is no specific code for 'Takeover Disclosure Form 8.5', and it is a mandatory regulatory announcement distributed via RNS, the most appropriate classification is the general regulatory filing category, RNS, as it is not a standard insider trade report (DIRS) but a specific disclosure related to a potential M&A event (Mediclinic International Plc is the offeree). Given the context of mandatory disclosure via RNS, RNS is the best fit among the provided options, although DIRS is related to the content (dealing disclosure). However, RNS serves as the general regulatory announcement fallback.
2023-02-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.